Show
Sort by
-
Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study
-
Mepolizumab for chronic rhinosinusitis with nasal polyps
-
Small airway loss in the physiologically ageing lung : a cross-sectional study in unused donor lungs
-
Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN) : a double-blind, randomised, phase 3A trial
-
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial
-
Organising international research in critical care medicine : current challenges and potential solutions
-
Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma : results from two phase 3, randomised, double-blind, placebo-controlled trials
-
- Journal Article
- A1
- open access
Chronic obstructive pulmonary disease and related phenotypes : polygenic risk scores in population-based and case-control cohorts
-
A new once-daily long-acting beta(2)-adrenoceptor agonist-inhaled corticosteroid combination therapy for asthma
-
Challenges in obstructive sleep apnoea